secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0001274737-22-000064
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen enters $50M ATM equity offering with Cowen and Company
-------------------------------------------------------------

- Agreement allows Exagen to sell up to $50M of common stock at market prices via Cowen as agent.
- Cowen receives 3% commission on gross proceeds; Company not obligated to sell any shares.
- Offering terminates upon sale of all shares or termination of the agreement.
- Shares sold through Nasdaq Global Market; prospectus supplement filed September 15, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/0001274737-22-000064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000064/exdx-20220915.htm
  HTML page:      https://secwatch.observer/filing/0001274737-22-000064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer